PERRY A KARSEN Insider Trading $JNCE Jounce Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PERRY A KARSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PERRY A KARSEN. PERRY A KARSEN is see remarks in CELGENE CORP /DE/ ($CELG) and Senior Vice President in HUMAN GENOME SCIENCES INC ($HGSI) and Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and Director in OncoMed Pharmaceuticals Inc ($OMED) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Voyager Therapeutics, Inc. ($VYGR) and Director in Jounce Therapeutics, Inc. ($JNCE) and Director in Intellia Therapeutics, Inc. ($NTLA).
PERRY A KARSEN in Jounce Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PERRY A KARSEN: Director
Holdings: 5,000 shares
Current Value: $86,500
Latest Transaction: Jun 29 2020
$JNCE Market Capitalization: $140.99M
$JNCE Previous Close: $17.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PERRY A KARSEN in Jounce Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, CELG, HGSI, NTLA, JNCE, NAVB, OMED, VYGR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2020 | JNCE | Jounce Therapeutic ... | KARSEN PERRY A | Director | Option Exercise | A | 7.58 | 13,550 | 102,709 | 13,550 | |
| Jun 13 2019 | JNCE | Jounce Therapeutic ... | KARSEN PERRY A | Director | Option Exercise | A | 4.46 | 15,700 | 70,022 | 15,700 | |
| Jun 21 2018 | JNCE | Jounce Therapeutic ... | KARSEN PERRY A | Director | Option Exercise | A | 7.92 | 13,550 | 107,316 | 13,550 | |
| Feb 02 2017 | JNCE | Jounce Therapeutic ... | KARSEN PERRY A | Director | Buy | P | 16.00 | 5,000 | 80,000 | 5,000 | 0 to 5 K |
Page: 1